Linda Burkly sold $19K of Editas Medicine stock
By AlphaYouPublished Form 4
Burkly Linda
Reporting filer
Linda Burkly reported selling 7,814 shares of Editas Medicine, Inc. for about $19K ($2.42 a share on average). Form 4 filed Nov 13, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 13, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Burkly Linda | 2026-11-11 | S | Sale | 7814 | 2.4155 | 70,379 | 2 days | Filed terms
|
Common Stock
- Owner
- Burkly Linda
- Date
- 2026-11-11
- Code
- S
- Action
- Sale
- Quantity
- 7814
- Price
- 2.4155
- Following holdings
- 70,379
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-11
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 7814
- transaction Price Per Share: 2.4155
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 70379
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Burkly Linda: EVP, CHIEF SCIENTIFIC OFFICER.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2026. The sale does not represent a discretionary trade by the Reporting Person.
- F2: This transaction was executed in multiple trades at prices ranging from $2.4150 to $2.4156. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Original sources
Prepared automatically from public filing data. Report a correction.